{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:11:09Z","timestamp":1792782669984,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical and Health Science and Technology Development Plan Project of Shandong Province","award":["No.202203070766"],"award-info":[{"award-number":["No.202203070766"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00415-026-13635-1","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T11:02:53Z","timestamp":1770116573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["NOACs effects in the secondary prevention of atrial fibrillation-related ischemic stroke\/TIA: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"273","author":[{"given":"Jiali","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fudi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"13635_CR1","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/s0140-6736(19)30427-1","volume":"394","author":"M Zhou","year":"2019","unstructured":"Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W et al (2019) Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 394:1145\u20131158. https:\/\/doi.org\/10.1016\/s0140-6736(19)30427-1","journal-title":"Lancet"},{"key":"13635_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s11883-006-0009-9","volume":"8","author":"B Murtagh","year":"2006","unstructured":"Murtagh B, Smalling RW (2006) Cardioembolic stroke. Curr Atheroscler Rep 8:310\u2013316. https:\/\/doi.org\/10.1007\/s11883-006-0009-9","journal-title":"Curr Atheroscler Rep"},{"key":"13635_CR3","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1161\/01.STR.0000166053.83476.4a","volume":"36","author":"C Marini","year":"2005","unstructured":"Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Totaro R et al (2005) Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 36:1115\u20131119. https:\/\/doi.org\/10.1161\/01.STR.0000166053.83476.4a","journal-title":"Stroke"},{"key":"13635_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4713826","volume":"2022","author":"Z Li","year":"2022","unstructured":"Li Z, Wang X, Li D, Wen A (2022) Real-world comparisons of low-dose NOACs versus standard-dose NOACs or warfarin on efficacy and safety in patients with AF: a meta-analysis. Cardiol Res Pract 2022:4713826. https:\/\/doi.org\/10.1155\/2022\/4713826","journal-title":"Cardiol Res Pract"},{"key":"13635_CR5","doi-asserted-by":"publisher","first-page":"f20","DOI":"10.1093\/ehjcvp\/pvz073","volume":"7","author":"A Silverio","year":"2021","unstructured":"Silverio A, Di Maio M, Prota C, De Angelis E, Radano I, Citro R et al (2021) Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: systematic review and meta-analysis of 22 studies and 440\u2009281 patients. Eur Heart J Cardiovasc Pharmacother 7:f20\u2013f29. https:\/\/doi.org\/10.1093\/ehjcvp\/pvz073","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"13635_CR6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46385","volume":"15","author":"P Basu Roy","year":"2023","unstructured":"Basu Roy P, Tejani VN, Dhillon SS, Damarlapally N, Winson T, Usman NUB et al (2023) Efficacy and safety of novel oral anticoagulants in atrial fibrillation: a systematic review. Cureus 15:e46385. https:\/\/doi.org\/10.7759\/cureus.46385","journal-title":"Cureus"},{"key":"13635_CR7","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/s1474-4422(10)70274-x","volume":"9","author":"HC Diener","year":"2010","unstructured":"Diener HC, Connolly SJ, Ezekowitz MD, Wallentin L, Reilly PA, Yang S et al (2010) Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial. Lancet Neurol 9:1157\u20131163. https:\/\/doi.org\/10.1016\/s1474-4422(10)70274-x","journal-title":"Lancet Neurol"},{"key":"13635_CR8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/s1474-4422(12)70092-3","volume":"11","author":"JD Easton","year":"2012","unstructured":"Easton JD, Lopes RD, Bahit MC, Wojdyla DM, Granger CB, Wallentin L et al (2012) Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial. Lancet Neurol 11:503\u2013511. https:\/\/doi.org\/10.1016\/s1474-4422(12)70092-3","journal-title":"Lancet Neurol"},{"key":"13635_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/s1474-4422(12)70042-x","volume":"11","author":"GJ Hankey","year":"2012","unstructured":"Hankey GJ, Patel MR, Stevens SR, Becker RC, Breithardt G, Carolei A et al (2012) Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol 11:315\u2013322. https:\/\/doi.org\/10.1016\/s1474-4422(12)70042-x","journal-title":"Lancet Neurol"},{"key":"13635_CR10","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.12.010","volume":"22","author":"N Tanahashi","year":"2013","unstructured":"Tanahashi N, Hori M, Matsumoto M, Momomura S, Uchiyama S, Goto S et al (2013) Rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation for the secondary prevention of stroke: a subgroup analysis of J-ROCKET AF. J Stroke Cerebrovasc Dis 22:1317\u20131325. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2012.12.010","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"13635_CR11","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.amjmed.2014.07.023","volume":"127","author":"TB Larsen","year":"2014","unstructured":"Larsen TB, Rasmussen LH, Gorst-Rasmussen A, Skj\u00f8th F, Lane DA, Lip GY (2014) Dabigatran and warfarin for secondary prevention of stroke in atrial fibrillation patients: a nationwide cohort study. Am J Med 127:1172-1178.e1175. https:\/\/doi.org\/10.1016\/j.amjmed.2014.07.023","journal-title":"Am J Med"},{"key":"13635_CR12","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1161\/strokeaha.116.013540","volume":"47","author":"NS Rost","year":"2016","unstructured":"Rost NS, Giugliano RP, Ruff CT, Murphy SA, Crompton AE, Norden AD et al (2016) Outcomes with edoxaban versus warfarin in patients with previous cerebrovascular events: findings from ENGAGE AF-TIMI 48 (effective anticoagulation with factor Xa next generation in atrial fibrillation-thrombolysis in myocardial infarction 48). Stroke 47:2075\u20132082. https:\/\/doi.org\/10.1161\/strokeaha.116.013540","journal-title":"Stroke"},{"key":"13635_CR13","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1161\/strokeaha.117.017474","volume":"48","author":"CI Coleman","year":"2017","unstructured":"Coleman CI, Peacock WF, Bunz TJ, Alberts MJ (2017) Effectiveness and safety of apixaban, dabigatran, and rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and previous stroke or transient ischemic attack. Stroke 48:2142\u20132149. https:\/\/doi.org\/10.1161\/strokeaha.117.017474","journal-title":"Stroke"},{"key":"13635_CR14","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamaneurol.2017.2161","volume":"74","author":"KS Hong","year":"2017","unstructured":"Hong KS, Kwon SU, Lee SH, Lee JS, Kim YJ, Song TJ et al (2017) Rivaroxaban vs warfarin sodium in the ultra-early period after atrial fibrillation-related mild ischemic stroke: a randomized clinical trial. JAMA Neurol 74:1206\u20131215. https:\/\/doi.org\/10.1001\/jamaneurol.2017.2161","journal-title":"JAMA Neurol"},{"key":"13635_CR15","first-page":"139","volume":"14","author":"H Jia-Gui","year":"2017","unstructured":"Jia-Gui H, Yan HE, Hua L, Yi-Ping T (2017) Clinical observation of low dose of dabigatran etexilate in the treatment of elderly stroke patients with atrial fibrillation. Pract Hosp Clin J 14:139\u2013140","journal-title":"Pract Hosp Clin J"},{"key":"13635_CR16","first-page":"1019","volume":"33","author":"J Jin","year":"2019","unstructured":"Jin J (2019) Comparison of the efficacy and safety of rivaroxaban and warfarin in anticoagulant therapy for patients with ischemic stroke complicated by nonvalvular atrial fibrillation. Pract Geriatr 33:1019\u20131021","journal-title":"Pract Geriatr"},{"key":"13635_CR17","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1001\/jamaneurol.2019.2099","volume":"76","author":"Y Xian","year":"2019","unstructured":"Xian Y, Xu H, O\u2019Brien EC, Shah S, Thomas L, Pencina MJ et al (2019) Clinical effectiveness of direct oral anticoagulants vs warfarin in older patients with atrial fibrillation and ischemic stroke: findings from the patient-centered research into outcomes stroke patients prefer and effectiveness research (PROSPER) study. JAMA Neurol 76:1192\u20131202. https:\/\/doi.org\/10.1001\/jamaneurol.2019.2099","journal-title":"JAMA Neurol"},{"key":"13635_CR18","first-page":"2596","volume":"40","author":"JH Xu","year":"2014","unstructured":"Xu JH, Xu YH, Cai ZR et al (2014) Comparison of the efficacy and safety of three different antithrombotic drugs for secondary prevention of nonvalvular atrial fibrillation ischemic stroke. Jilin Med 40:2596\u20132599","journal-title":"Jilin Med"},{"key":"13635_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/2040622320974853","volume":"11","author":"SF Lin","year":"2020","unstructured":"Lin SF, Lu YH, Bai CH (2020) Risk of recurrent stroke for Asian stroke patients treated with non-vitamin K antagonist oral anticoagulant and warfarin. Ther Adv Chronic Dis 11:2040622320974853. https:\/\/doi.org\/10.1177\/2040622320974853","journal-title":"Ther Adv Chronic Dis"},{"key":"13635_CR20","first-page":"674","volume":"28","author":"X Xia","year":"2020","unstructured":"Xia X, Zhu Q, Liang S et al (2020) Comparison of anticoagulant efficacy and safety of dabigatran etexilate and warfarin in the treatment of atrial fibrillation with stroke. J Brain Nerv Dis 28:674\u2013678","journal-title":"J Brain Nerv Dis"},{"key":"13635_CR21","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1161\/strokeaha.120.030042","volume":"52","author":"AJ Labovitz","year":"2021","unstructured":"Labovitz AJ, Rose DZ, Fradley MG, Meriwether JN, Renati S, Martin R et al (2021) Early apixaban use following stroke in patients with atrial fibrillation: results of the AREST trial. Stroke 52:1164\u20131171. https:\/\/doi.org\/10.1161\/strokeaha.120.030042","journal-title":"Stroke"},{"key":"13635_CR22","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1177\/23969873241242239","volume":"9","author":"HC Diener","year":"2024","unstructured":"Diener HC, Grosse GM, H\u00fcsing A, Stang A, Kuklik N, Brinkmann M et al (2024) Efficacy and safety of oral factor Xa inhibitors versus vitamin-K antagonists in the early phase after acute ischemic stroke or TIA in the real-world setting: the PRODAST study. Eur Stroke J 9:696\u2013703. https:\/\/doi.org\/10.1177\/23969873241242239","journal-title":"Eur Stroke J"},{"key":"13635_CR23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/0735-1097(94)00396-8","volume":"25","author":"MF Stoddard","year":"1995","unstructured":"Stoddard MF, Dawkins PR, Prince CR, Ammash NM (1995) Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol 25:452\u2013459. https:\/\/doi.org\/10.1016\/0735-1097(94)00396-8","journal-title":"J Am Coll Cardiol"},{"key":"13635_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijcard.2003.02.007","volume":"95","author":"R Pujadas Capmany","year":"2004","unstructured":"Pujadas Capmany R, Arboix A, Casa\u00f1as-Mu\u00f1oz R, Anguera-Ferrando N (2004) Specific cardiac disorders in 402 consecutive patients with ischaemic cardioembolic stroke. Int J Cardiol 95:129\u2013134. https:\/\/doi.org\/10.1016\/j.ijcard.2003.02.007","journal-title":"Int J Cardiol"},{"key":"13635_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000255973","volume":"29","author":"N Hannon","year":"2010","unstructured":"Hannon N, Sheehan O, Kelly L, Marnane M, Merwick A, Moore A et al (2010) Stroke associated with atrial fibrillation\u2013incidence and early outcomes in the north Dublin population stroke study. Cerebrovasc Dis 29:43\u201349. https:\/\/doi.org\/10.1159\/000255973","journal-title":"Cerebrovasc Dis"},{"key":"13635_CR26","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","volume":"64","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr et al (2014) 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 64:e1-76. https:\/\/doi.org\/10.1016\/j.jacc.2014.03.022","journal-title":"J Am Coll Cardiol"},{"key":"13635_CR27","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.hrthm.2018.05.019","volume":"15","author":"FE Ugowe","year":"2018","unstructured":"Ugowe FE, Jackson LR 2nd, Thomas KL (2018) Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: a systematic review. Heart Rhythm 15:1337\u20131345. https:\/\/doi.org\/10.1016\/j.hrthm.2018.05.019","journal-title":"Heart Rhythm"},{"key":"13635_CR28","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/phar.1133","volume":"32","author":"CE Mahan","year":"2012","unstructured":"Mahan CE, Kaatz S (2012) Performance of new anticoagulants for thromboprophylaxis in patients undergoing hip and knee replacement surgery. Pharmacotherapy 32:1036\u20131048. https:\/\/doi.org\/10.1002\/phar.1133","journal-title":"Pharmacotherapy"},{"key":"13635_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60010101","author":"M Inog\u00e9s","year":"2024","unstructured":"Inog\u00e9s M, Arboix A, Garc\u00eda-Eroles L, S\u00e1nchez-L\u00f3pez MJ (2024) Gender predicts differences in acute ischemic cardioembolic stroke profile: emphasis on woman-specific clinical data and early outcome-the experience of Sagrat Cor Hospital of Barcelona Stroke Registry. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina60010101","journal-title":"Medicina (Kaunas)"},{"key":"13635_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.12998\/wjcc.v5.i3.93","volume":"5","author":"A Arboix","year":"2017","unstructured":"Arboix A, Mart\u00ed L, Dorison S, S\u00e1nchez MJ (2017) Bay\u00e9s syndrome and acute cardioembolic ischemic stroke. World J Clin Cases 5:93\u2013101. https:\/\/doi.org\/10.12998\/wjcc.v5.i3.93","journal-title":"World J Clin Cases"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13635-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13635-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13635-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:05:11Z","timestamp":1773785111000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13635-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["13635"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13635-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"113"}}